These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
591 related articles for article (PubMed ID: 34806464)
1. Post-transplantation Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Lymphoblastic Lymphoma is an Independent Prognostic Factor with an Impact on Progression-Free Survival but not Overall Survival. Dai N; Liu H; Deng S; Sang S; Wu Y Technol Cancer Res Treat; 2021; 20():15330338211056478. PubMed ID: 34806464 [No Abstract] [Full Text] [Related]
2. Prognostic Value of 2-Deoxy-2-[ Dai N; Zhou Y; Deng S; Sang S; Wu Y Contrast Media Mol Imaging; 2021; 2021():5510825. PubMed ID: 33958977 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of Sun N; Qiao W; Xing Y; Wang T; Yang J; Zhao J Clin Transl Oncol; 2021 Aug; 23(8):1571-1576. PubMed ID: 33449269 [TBL] [Abstract][Full Text] [Related]
4. Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients. Bouard L; Bodet-Milin C; Bailly C; Guillaume T; Peterlin P; Garnier A; Bourgeois AL; Mahé B; Dubruille V; Blin N; Touzeau C; Gastinne T; Lok A; Bonnet A; Béné MC; Gouill SL; Moreau P; Kraeber-Bodéré F; Chevallier P Biol Blood Marrow Transplant; 2019 May; 25(5):906-911. PubMed ID: 30481598 [TBL] [Abstract][Full Text] [Related]
5. The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation. Patriarca F; Carobolante F; Zamagni E; Montefusco V; Bruno B; Englaro E; Nanni C; Geatti O; Isola M; Sperotto A; Buttignol S; Stocchi R; Corradini P; Cavo M; Fanin R Biol Blood Marrow Transplant; 2015 Jun; 21(6):1068-73. PubMed ID: 25754658 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of FDG PET/CT before Allogeneic and Autologous Stem Cell Transplantation for Aggressive Lymphoma. Ulaner GA; Goldman DA; Sauter CS; Migliacci J; Lilienstein J; Gönen M; Schöder H; Moskowitz CH; Zelenetz AD Radiology; 2015 Nov; 277(2):518-26. PubMed ID: 26035588 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation. Spaepen K; Stroobants S; Dupont P; Vandenberghe P; Maertens J; Bormans G; Thomas J; Balzarini J; De Wolf-Peeters C; Mortelmans L; Verhoef G Blood; 2003 Jul; 102(1):53-9. PubMed ID: 12609836 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of [ Stolzenburg A; Lückerath K; Samnick S; Speer M; Kneer K; Schmid JS; Grigoleit GU; Hofmann S; Beer AJ; Bunjes D; Knop S; Buck AK; Einsele H; Lapa C Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1694-1704. PubMed ID: 29610955 [TBL] [Abstract][Full Text] [Related]
10. Impact of Pretransplantation (18)F-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin Lymphoma. Reyal Y; Kayani I; Bloor AJC; Fox CP; Chakraverty R; Sjursen AM; Fielding AK; Ben Taylor M; Bishton MJ; Morris EC; Thomson KJ; Russell N; Mackinnon S; Peggs KS Biol Blood Marrow Transplant; 2016 Jul; 22(7):1234-1241. PubMed ID: 27095691 [TBL] [Abstract][Full Text] [Related]
11. Prognostic role of baseline Albano D; Bosio G; Camoni L; Farina M; Re A; Tucci A; Giubbini R; Bertagna F Hematol Oncol; 2019 Feb; 37(1):39-46. PubMed ID: 30299563 [TBL] [Abstract][Full Text] [Related]
12. [Prognostic evaluation value of (18)F-FDG PET-CT in Hodgkin's lymphoma after treatment]. Wan H; Liu P; Liang Y; Jiang SY; Lyu L; Zhang ZW; Wu N; Liu Y Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1275-1281. PubMed ID: 34915636 [No Abstract] [Full Text] [Related]
13. [Diagnostic and Prognostic Value of Chen X; Qiao WL; Song JH; Liu CC; Han L; Wu S; Zhao JH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1044-1049. PubMed ID: 37551475 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma. Alongi P; Evangelista L; Caobelli F; Spallino M; Gianolli L; Midiri M; Picchio M Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):85-94. PubMed ID: 28828589 [TBL] [Abstract][Full Text] [Related]
15. Midtreatment ¹⁸F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center. Khong PL; Huang B; Lee EY; Chan WK; Kwong YL J Nucl Med; 2014 Jun; 55(6):911-6. PubMed ID: 24819420 [TBL] [Abstract][Full Text] [Related]
16. Baseline Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT Predict Outcomes in T-Cell Lymphoblastic Lymphoma. Feng X; Wen X; Li L; Sun Z; Li X; Zhang L; Wu J; Fu X; Wang X; Yu H; Ma X; Zhang X; Xie X; Han X; Zhang M Cancer Res Treat; 2021 Jul; 53(3):837-846. PubMed ID: 33285054 [TBL] [Abstract][Full Text] [Related]
17. Analysis of Positive Results of Dai N; Cai R; Deng S; Sang S Diagnostics (Basel); 2023 Jun; 13(12):. PubMed ID: 37370922 [TBL] [Abstract][Full Text] [Related]
18. Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation. Qiao W; Zhao J; Wang C; Wang T; Xing Y Hematology; 2010 Feb; 15(1):21-7. PubMed ID: 20132658 [TBL] [Abstract][Full Text] [Related]
19. [Prognostic significance of (18)F-fluorodeoxyglucose positron emission tomography in patients with diffuse large B cell lymphoma undergoing autologous stem cell transplantation]. Ying ZT; Mi L; Wang XJ; Zhang YW; Yang Z; Song YQ; Wang XP; Zheng W; Lin NJ; Tu MF; Xie Y; Ping LY; Zhang C; Liu WP; Deng LJ; Zhu J Zhonghua Xue Ye Xue Za Zhi; 2018 May; 39(5):382-386. PubMed ID: 29779346 [No Abstract] [Full Text] [Related]
20. Dynamic evaluation of the prognostic value of Xu P; Guo R; You J; Cheng S; Li J; Zhong H; Sun C; Xu H; Huang H; Li B; Zhao W Ann Hematol; 2021 Apr; 100(4):1039-1047. PubMed ID: 33634350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]